You have 9 free searches left this month | for more free features.

City

Tianjin (2)

Beijing (1)

Haikou (1)

Shijiazhuang (1)

Condition

Acute Myeloid Leukemia (1)

Acute Myeloid Leukemia With FLT3/ITD Mutation (1)

Advanced or Metastatic Solid Tumours (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Unknown status (1)

Sign in for free

Phase

phase 1 (2)

phase 3 (1)

Sponsor

Shijiazhuang Yiling Pharmaceutical Co. Ltd (3)

Collaborator

Proswell Medical Corporation (1)

Tigermed Consulting Co., Ltd (1)

Intervention

xy0206 (3)

salvage chemotherapy (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

xy0206

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Acute Myeloid Leukemia With FLT3/ITD Mutation Trial (XY0206, Salvage Chemotherapy)

Not yet recruiting

Acute Myeloid Leukemia With FLT3/ITD Mutation

XY0206
Salvage Chemotherapy

(no location specified)

May 24, 2023

Acute Myeloid Leukemia Trial in Tianjin (XY0206)

Recruiting

Acute Myeloid Leukemia

XY0206

Tianjin, Tianjin, China

Institute of Hematology, Chinese Academy of Medical Sciences

Dec 11, 2021

Advanced or Metastatic Solid Tumours Trial in China (XY0206)

Unknown status

Advanced or Metastatic Solid Tumours

XY0206

Beijing, Beijing, China
+3 more

Aug 19, 2020